198 related articles for article (PubMed ID: 9392480)
21. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
[TBL] [Abstract][Full Text] [Related]
22. Hyperinsulinemia and its impact on obesity and insulin resistance.
Cusin I; Rohner-Jeanrenaud F; Terrettaz J; Jeanrenaud B
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S1-11. PubMed ID: 1338381
[TBL] [Abstract][Full Text] [Related]
23. Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate.
Forcheron F; Basset A; Del Carmine P; Beylot M
Diabetes Metab; 2009 Dec; 35(6):452-7. PubMed ID: 19854668
[TBL] [Abstract][Full Text] [Related]
24. Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acid.
Kalderon B; Hertz R; Bar-Tana J
Endocrinology; 1992 Oct; 131(4):1629-35. PubMed ID: 1396307
[TBL] [Abstract][Full Text] [Related]
25. Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.
Reeds DN; Yarasheski KE; Fontana L; Cade WT; Laciny E; DeMoss A; Patterson BW; Powderly WG; Klein S
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E47-E53. PubMed ID: 16118251
[TBL] [Abstract][Full Text] [Related]
26. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
27. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
Bar-Tana J; Rose-Kahn G; Frenkel B; Shafer Z; Fainaru M
J Lipid Res; 1988 Apr; 29(4):431-41. PubMed ID: 3392461
[TBL] [Abstract][Full Text] [Related]
28. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
29. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
[TBL] [Abstract][Full Text] [Related]
30. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue.
Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats.
Crist GH; Xu B; Lanoue KF; Lang CH
FASEB J; 1998 Oct; 12(13):1301-8. PubMed ID: 9761773
[TBL] [Abstract][Full Text] [Related]
32. Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver.
Cusin I; Terrettaz J; Rohner-Jeanrenaud F; Jeanrenaud B
Biochem J; 1990 Apr; 267(1):99-103. PubMed ID: 2183797
[TBL] [Abstract][Full Text] [Related]
33. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.
de Souza CJ; Hirshman MF; Horton ES
Diabetes; 1997 Aug; 46(8):1257-63. PubMed ID: 9231648
[TBL] [Abstract][Full Text] [Related]
34. Effect of beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16) on laying hen performance and egg yolk lipid composition.
Elkin RG; Rogler JC; Lee HD; Watkins BA
Br Poult Sci; 1992 Jul; 33(3):677-81. PubMed ID: 1643530
[TBL] [Abstract][Full Text] [Related]
35. Effect of the new oral antidiabetic agent (-)-BM 13.0913.Na on insulin resistance in lean and obese Zucker rats.
Apweiler R; Kühnle HF; Ritter G; Schell R; Freund P
Metabolism; 1995 May; 44(5):577-83. PubMed ID: 7752904
[TBL] [Abstract][Full Text] [Related]
36. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals.
Daniele G; Eldor R; Merovci A; Clarke GD; Xiong J; Tripathy D; Taranova A; Abdul-Ghani M; DeFronzo RA
Diabetes; 2014 Aug; 63(8):2812-20. PubMed ID: 24353180
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
[TBL] [Abstract][Full Text] [Related]
38. Adipose tissue, hepatic, and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans.
Reeds DN; Stuart CA; Perez O; Klein S
Metabolism; 2006 Dec; 55(12):1658-63. PubMed ID: 17142140
[TBL] [Abstract][Full Text] [Related]
39. Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
Guillaume-Gentil C; Assimacopoulos-Jeannet F; Jeanrenaud B
Diabetologia; 1993 Oct; 36(10):899-906. PubMed ID: 8243867
[TBL] [Abstract][Full Text] [Related]
40. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats.
Atkinson LL; Kelly SE; Russell JC; Bar-Tana J; Lopaschuk GD
Diabetes; 2002 May; 51(5):1548-55. PubMed ID: 11978655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
